Clinical Profile and Outcome of Pediatric Mitochondrial Myopathy in China

Overview

Journal Front Neurol

Specialty Neurology

Date 2020 Oct 5

PMID 33013660

Citations 5

Authors

Chaoping Hu

Xihua Li

Lei Zhao

Yiyun Shi

Shuizhen Zhou

Yi Wang

Affiliations

Soon will be listed here.

Abstract

Mitochondrial myopathy in children has notable clinical and genetic heterogeneity, but detailed data is lacking. In this study, we retrospectively reviewed the clinical presentation, laboratory investigation, genetic and histopathological characteristics, and follow-ups of 21 pediatric mitochondrial myopathy cases from China. Twenty-four patients suspected with mitochondrial myopathy were enrolled initially and 21 were genetically identified. Fourteen patients were found to harbor mitochondrial DNA point mutations (14/21, 66.7%), including m.3243A>G (9/15, 60%), m.3303C>T (2/15, 13.3%), m.3302A>G (1/15, 6.7%), m.3250T>C (1/15, 6.7%), m.3251A>G (1/15, 6.7%), of whom 12 patients presented with progressive proximal mitochondrial myopathy (12/14, 85.7%). Three patients revealed large-scale deletion in blood or muscle tissue (3/21, 14.3%), presenting with Kearns-Sayer syndrome (1/3, 33.3%) or chronic progressive external ophthalmoplegia (2/3, 66.7%). Four patients were found to harbor pathogenic nuclear gene variants (4/21, 19.0%), including five variants in gene and two variants in gene. During the follow-ups up to 7 years, 10 patients developed cardiomyopathy (10/21, 47.6%), 13 patients occurred at least once hypercapnic respiratory failure (13/21, 61.9%), six experienced recurrent respiratory failure and intubation (6/21, 28.6%), eight patients failed to survive (8/21, 38.1%). With nocturnal non-invasive ventilation of BiPAP, three patients recovered from respiratory failure, and led a relative stable and functional life (3/21, 14.3%). Mitochondrial myopathy in children has great clinical, pathological, and genetical heterogeneity. Progressive proximal myopathy is most prevalent. Mitochondrial DNA point mutations are most common. And respiratory failure is a critical risk factor of poor prognosis.

Citing Articles

Clinical and molecular spectrum of TK2-deficiency: a large Brazilian cohort.

Moreno C, Artilheiro M, Fonseca A, da Silva A, Fernandes T, Camelo C Sci Rep. 2025; 15(1):9013.

PMID: 40089535 DOI: 10.1038/s41598-024-84373-5.

Heteroplasmy and Individual Mitogene Pools: Characteristics and Potential Roles in Ecological Studies.

Wang W, Lin L, Zhang Q, Yang J, Kamili E, Chu J Biology (Basel). 2023; 12(11).

PMID: 37998051 PMC: 10669347. DOI: 10.3390/biology12111452.

Reversible cardiac function and left ventricular hypertrophy in a Chinese man with mitochondrial myopathy: a case report.

Wu G, Han Y, Zhao L, Zhang H, Fan X, Li W BMC Cardiovasc Disord. 2023; 23(1):464.

PMID: 37715114 PMC: 10503081. DOI: 10.1186/s12872-023-03444-z.

A patient with MELAS syndrome combined with autoimmune abnormalities: a case report.

Zhao M, Zuo C, Hao H, Xing X, Zhao L, Li N Front Neurol. 2023; 14:1239664.

PMID: 37693769 PMC: 10484216. DOI: 10.3389/fneur.2023.1239664.

Clinicopathologic Features of Mitochondrial Nephropathy.

Imasawa T, Hirano D, Nozu K, Kitamura H, Hattori M, Sugiyama H Kidney Int Rep. 2022; 7(3):580-590.

PMID: 35257070 PMC: 8897298. DOI: 10.1016/j.ekir.2021.12.028.

References

Houshmand M, Larsson N, Oldfors A, Tulinius M, Holme E . Fatal mitochondrial myopathy, lactic acidosis, and complex I deficiency associated with a heteroplasmic A --> G mutation at position 3251 in the mitochondrial tRNALeu(UUR) gne. Hum Genet. 1996; 97(3):269-73. DOI: 10.1007/BF02185750. View

Broomfield A, Sweeney M, Woodward C, Fratter C, Morris A, Leonard J . Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease. J Inherit Metab Dis. 2014; 38(3):445-57. PMC: 4432108. DOI: 10.1007/s10545-014-9778-4. View

Ahmed S, Craven L, Russell O, Turnbull D, Vincent A . Diagnosis and Treatment of Mitochondrial Myopathies. Neurotherapeutics. 2018; 15(4):943-953. PMC: 6277287. DOI: 10.1007/s13311-018-00674-4. View

Russell O, Gorman G, Lightowlers R, Turnbull D . Mitochondrial Diseases: Hope for the Future. Cell. 2020; 181(1):168-188. DOI: 10.1016/j.cell.2020.02.051. View

Zhang W, Cui H, Wong L . Comprehensive one-step molecular analyses of mitochondrial genome by massively parallel sequencing. Clin Chem. 2012; 58(9):1322-31. DOI: 10.1373/clinchem.2011.181438. View

Ueki I, Koga Y, Povalko N, Akita Y, Nishioka J, Yatsuga S . Mitochondrial tRNA gene mutations in patients having mitochondrial disease with lactic acidosis. Mitochondrion. 2005; 6(1):29-36. DOI: 10.1016/j.mito.2005.10.003. View

Zhou Y, Yi J, Liu L, Wang X, Dong L, Du A . Acute mitochondrial myopathy with respiratory insufficiency and motor axonal polyneuropathy. Int J Neurosci. 2017; 128(3):231-236. DOI: 10.1080/00207454.2017.1387113. View

Catteruccia M, Sauchelli D, Della Marca G, Primiano G, Cuccagna C, Bernardo D . "Myo-cardiomyopathy" is commonly associated with the A8344G "MERRF" mutation. J Neurol. 2015; 262(3):701-10. DOI: 10.1007/s00415-014-7632-0. View

Ogle R, Christodoulou J, Fagan E, Blok R, Kirby D, Seller K . Mitochondrial myopathy with tRNA(Leu(UUR)) mutation and complex I deficiency responsive to riboflavin. J Pediatr. 1997; 130(1):138-45. DOI: 10.1016/s0022-3476(97)70323-8. View

10.

Lee I, El-Hattab A, Wang J, Li F, Weng S, Craigen W . SURF1-associated Leigh syndrome: a case series and novel mutations. Hum Mutat. 2012; 33(8):1192-200. DOI: 10.1002/humu.22095. View

11.

Nesbitt V, Pitceathly R, Turnbull D, Taylor R, Sweeney M, Mudanohwo E . The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation--implications for diagnosis and management. J Neurol Neurosurg Psychiatry. 2013; 84(8):936-8. DOI: 10.1136/jnnp-2012-303528. View

12.

Koo P, Sethi J . Metabolic Myopathies and the Respiratory System. Clin Chest Med. 2018; 39(2):401-410. DOI: 10.1016/j.ccm.2018.02.001. View

13.

Chanprasert S, Wang J, Weng S, Enns G, Boue D, Wong B . Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene. Mol Genet Metab. 2013; 110(1-2):153-61. DOI: 10.1016/j.ymgme.2013.07.009. View

14.

Hu C, Li X, Zhao L, Shi Y, Zhou S, Wu B . Clinical and molecular characterization of pediatric mitochondrial disorders in south of China. Eur J Med Genet. 2020; 63(8):103898. DOI: 10.1016/j.ejmg.2020.103898. View

15.

Hardy S, Blakely E, Purvis A, Rocha M, Ahmed S, Falkous G . Pathogenic mtDNA mutations causing mitochondrial myopathy: The need for muscle biopsy. Neurol Genet. 2016; 2(4):e82. PMC: 4972142. DOI: 10.1212/NXG.0000000000000082. View

16.

Naddaf E, Milone M . Hereditary myopathies with early respiratory insufficiency in adults. Muscle Nerve. 2017; 56(5):881-886. DOI: 10.1002/mus.25602. View

17.

Taylor R, Schaefer A, Barron M, McFarland R, Turnbull D . The diagnosis of mitochondrial muscle disease. Neuromuscul Disord. 2004; 14(4):237-45. DOI: 10.1016/j.nmd.2003.12.004. View

18.

Garone C, Viscomi C . Towards a therapy for mitochondrial disease: an update. Biochem Soc Trans. 2018; 46(5):1247-1261. PMC: 6195631. DOI: 10.1042/BST20180134. View

19.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

20.

Lu Y, Zhao D, Yao S, Wu S, Hong D, Wang Q . Mitochondrial tRNA genes are hotspots for mutations in a cohort of patients with exercise intolerance and mitochondrial myopathy. J Neurol Sci. 2017; 379:137-143. DOI: 10.1016/j.jns.2017.05.056. View